{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "BBWI",
  "name": "Bath & Body Works, Inc.",
  "url": "https://orbyd.app/dossiers/BBWI/",
  "json_url": "https://orbyd.app/dossiers/BBWI.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Rotation-passenger thesis is dead and the self-help turnaround hasn't ignited: BBWI made fresh relative lows near $19 into the 2026-07-12 Ulta launch, down ~42% over 12 months and below its 200-DMA while the tape holds up. Goldman cut to Sell (07-08). Cheap at ~6x, but structurally broken — a value trap, not a momentum setup, into a late-August Q2 print.",
  "invalidation_trigger": "A weekly close below $18 loses the summer basing shelf and reopens the $14.28 52-week low, confirming the value trap; a Q2 print (~2026-08-27) that steepens net-sales declines past the down-2.5%-to-4.5% FY guide with no offsetting raise seals it.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "consumer-discretionary-rotation",
    "small-cap-value-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Structure reset: prior high-$20s base is BROKEN and now resistance; stock lives low-$20s. Constructive only on a volume close back above ~$26; bear confirms on weekly close below $18.",
    "Leadership churn: CFO Eva Boratto departed 2026-06-12 (interim + active search); CEO Daniel Heaf (ex-Nike) still year-two and unproven. Turnaround optionality only matters on one positive comp quarter.",
    "Watch the stale-consensus trap: some screens still show a ~$38.97 average target; current desks cluster $19–$26 (Wells Fargo Overweight $26, 06-24). Use the current cluster.",
    "No company earnings inside next 30d — next binary is Q2 FY2026, ~2026-08-27 (est., before open). Do not size for an earnings move until late Aug; consensus ~$0.36 EPS / ~$1.55B rev, roughly flat YoY.",
    "2026-07-12 Ulta launch (600+ doors, 55+ SKUs) is live but produced no durable bid; international rollout to 40+ markets phased through late 2026 — track sell-through, not the announcement.",
    "Live analyst cluster ~$19–$26 (Goldman Sell $19, 2026-07-08; Morgan Stanley EW $22; Wells Fargo OW $26). Ignore the stale ~$38 average some screens still show.",
    "Structure: high-$20s base broken and now resistance; stock lives sub-$20 below the 200-DMA. Constructive only on a volume reclaim above ~$26; downtrend confirms on weekly close below $18.",
    "Decoupled from the discretionary cohort to the downside since early 2026 — treat weakness as idiosyncratic, not macro. CEO Daniel Heaf (ex-Nike) year two; CFO transition after Eva Boratto's 2026-06-12 exit."
  ],
  "body_markdown": "## Current Thesis\nThe rotation-passenger read is dead and the self-help turnaround has not ignited. BBWI traded near $19.21 on 2026-07-24, down roughly 42% over the trailing twelve months and sitting just above its $14.28 52-week low while the broad tape holds near records — a name decoupled to the downside, below its 200-day average, with no reclaim in sight. The single bullish catalyst of the quarter, the 2026-07-12 launch into 600+ Ulta Beauty doors, came and went without a durable bid; the stock printed fresh relative lows into the event. Goldman Sachs cut it to Sell on 2026-07-08 with a $19 target. At roughly 6x earnings and a 3.8% yield the valuation is cheap, but cheap paired with a nine-month downtrend is a value trap for a momentum book, not a setup.\n\n## Bull Case\n- **New wholesale channel is live and scaling**: BBWI entered 600+ Ulta Beauty stores and Ulta.com on 2026-07-12 with 55+ SKUs (including Juniper Breeze), the first material step beyond its ~1,800 owned doors; a phased international rollout to 40+ markets is planned through late 2026.\n- **Q1 FY2026 (reported ~2026-05-27) cleared a low bar**: net sales ~$1.38B and adjusted EPS ~$0.32, evidence the Consumer First Formula is defending margin as comps soften.\n- **Valuation and capital return are real**: ~5.9x trailing P/E, ~3.8% dividend yield, ~$3.87B market cap, with free cash flow funding a buyback that shrinks the float even on flat-to-down sales.\n- **Category share intact**: #1 U.S. position in body care and home fragrance gives the turnaround a re-merchandising asset, and part of the desk still leans constructive — Wells Fargo Overweight, $26 target.\n- **Sentiment is washed out**: at a 52-week-low zone with a fresh Sell rating already in the tape, expectations into the late-August print are low enough that a single positive comp quarter would re-rate a heavily de-rated multiple.\n\n## Bear Case\n- **Price structure is broken and deteriorating**: at ~$19.21 (2026-07-24) the stock sits nearer its $14.28 low than any prior support, below the 200-day average, and roughly $3 below where it changed hands at the early-July review — continuation lower, not a base.\n- **The one catalyst was a non-event**: the 2026-07-12 Ulta launch produced no durable move; Jefferies flagged the deal as largely channel shift rather than net-new customer acquisition.\n- **Estimates are being cut**: Goldman Sachs downgraded to Sell (2026-07-08, $19 PT) and Morgan Stanley resumed at Equal Weight ($22); the live desk cluster now spans ~$19–$26, well beneath the stale ~$38 average some screens still display.\n- **The business is guided to shrink**: FY2026 net sales guided down 2.5%–4.5% against the $7,291M FY2025 base — a contracting top line the turnaround has yet to inflect.\n- **Leadership is unsettled**: a year-two, still-unproven CEO (Daniel Heaf, ex-Nike) alongside a CFO transition after Eva Boratto's 2026-06-12 departure leaves the self-help plan without a fully seated finance chief.\n\n## Setup & Price Structure\nBBWI changes hands near $19.21 inside a 52-week range of $14.28–$32.95, about 43% under the mid-2025 high and below its 200-day moving average. The high-$20s multi-year base failed months ago and is now overhead supply; the low-$20s shelf the prior review leaned on has also given way. The operative level is the summer basing shelf near $18 — it has held on a closing basis so far, and a weekly close beneath it reopens the $14.28 low with little structure in between. To the upside, nothing constructive triggers until a volume reclaim of the low-$20s and then the ~$26 desk-cluster ceiling. Until one of those lines resolves, this is a downtrending name grinding along its lows: the kind of chart a momentum book fades or ignores, where the discipline that matters is not buying weakness because the multiple looks cheap.\n\n## Catalyst Calendar (next 30 days)\n\n- **No company-specific binary inside 30 days.** The next hard catalyst is the Q2 FY2026 print, expected ~2026-08-27 (est., before the open) — outside this window. Consensus sits near $0.36 EPS on ~$1.55B revenue, roughly flat versus the ~$0.37/$1.5B posted in Q2 a year earlier.\n- **Macro/consumer prints**: July retail-sales and discretionary-spend data land mid-August and set the cohort tone; BBWI trades as correlated discretionary risk into them.\n- No FDA/PDUFA, no scheduled analyst day, no dividend action expected inside the window.\n\n## Elapsed catalysts\n\n- **Ulta sell-through read (ongoing, from 2026-07-12)**: early Ulta.com and in-store velocity and any BBWI/Ulta channel commentary are the only live company data points before the print — watch third-party checks, not a press release. *(passed 21d ago)*\n\n## What Would Change Our Mind\n- **A weekly close back above ~$26** (the top of the live desk cluster and prior resistance) on expanding volume would flip the structure from broken to basing and re-open the turnaround as a tradable long.\n- **A Q2 print (~2026-08-27) that turns comps positive and prompts an FY guide raise** — the first hard proof the Consumer First Formula and Ulta channel are additive rather than defensive — would convert the value-trap read into an earnings-inflection setup.\n- **Clustered upgrades reversing the Goldman/Jefferies caution**, or evidence of durable Ulta sell-through as opposed to channel shift, would signal the narrative is finally accelerating rather than eroding.\n- Conversely, a weekly close below $18 confirms the downtrend and removes any remaining reason to carry it as a watch-list long.\n\n## Correlation Notes\nBBWI behaves as a high-beta consumer-discretionary and specialty-retail name, historically tracking the discretionary cohort and consumer-spending data, but it has decoupled to the downside through 2026 — sector strength is not lifting it, which marks the weakness as idiosyncratic. Read-through runs both ways with mall-based specialty retail and beauty peers (Ulta itself as the new wholesale partner, plus ELF and other body-care and fragrance names); a broad discretionary risk-off would pressure it further, while cohort strength alone has failed to bid it. Its turnaround optionality means single-stock news — comp prints, channel data, management moves — drives the tape more than macro on any given week.",
  "first_seen": "2026-06-18",
  "last_analyzed": "2026-07-25T08:23:01+00:00",
  "last_synthesized": "2026-07-25",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}